Trial of Orencia in Patients With Myasthenia Gravis
Status:
Terminated
Trial end date:
2019-07-15
Target enrollment:
Participant gender:
Summary
This pilot research study is being done to see if the drug abatacept (Orencia ®) will be
helpful in treating patients with myasthenia gravis (MG) who do not respond satisfactorily to
other drugs that are used to suppress the immune system. Abatacept has been successful in
treating experimental MG in laboratory animals, and this study is to determine its
effectiveness in patients with MG.